2021
DOI: 10.5114/aic.2021.109149
|View full text |Cite
|
Sign up to set email alerts
|

Predictors of mortality following extracorporeal membrane oxygenation support in an unselected, critically ill patient population

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
7
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
5
1

Relationship

1
5

Authors

Journals

citations
Cited by 7 publications
(7 citation statements)
references
References 27 publications
0
7
0
Order By: Relevance
“…Some studies demonstrated that malignancy, history of revascularization, duration of cardiac arrest, heart failure, male gender, pH < 7.3, age ≥65 years, and low BMI are predictors for mortality in ECMO patients. 17,18 Chen and colleagues found that long-term mortality was associated with older age, left main disease, and high VIS. 19 Burrel and coworkers found that higher lactate, ischemic heart disease, renal replacement, and higher bilirubin predicted mortality after venoarterial ECMO.…”
Section: Discussionmentioning
confidence: 99%
“…Some studies demonstrated that malignancy, history of revascularization, duration of cardiac arrest, heart failure, male gender, pH < 7.3, age ≥65 years, and low BMI are predictors for mortality in ECMO patients. 17,18 Chen and colleagues found that long-term mortality was associated with older age, left main disease, and high VIS. 19 Burrel and coworkers found that higher lactate, ischemic heart disease, renal replacement, and higher bilirubin predicted mortality after venoarterial ECMO.…”
Section: Discussionmentioning
confidence: 99%
“…Nonetheless, in the absence of internationally accepted CS ACS pVA-ECMO initialization guidelines, our center has developed its own protocol (Figure 2), based on available literature data and empirical findings from our own clinical study using one of the largest single-center databases among the specialized institutions worldwide (34). The protocol considers multiple factors, such as clinical condition, age, low-flow times, and comorbidities.…”
Section: Patient Selectionmentioning
confidence: 99%
“…The availability and application numbers of extracorporeal life support (ECLS) and extracorporeal membrane oxygenation (ECMO) are continuously increasing in cardiac surgery centers [ 1 , 2 ]. Even though ECLS and ECMO are complex therapies that require high-level specialized centers, the first multidisciplinary guideline for the organization and application of ECMO therapy for cardiocirculatory support was published in 2021 [ 3 ].…”
Section: Introductionmentioning
confidence: 99%